Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report-Reference-Cited by-同舟云学术

Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report

Published:2019-12-18 Issue:2 Volume:99 Page:223-228
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Jo Jae-Cheol^ORCID, ,Kim Seok Jin,Lee Ho Sup,Eom Hyeon-Seok,Lee Soon Il,Park Yong,Lee Jeong-Ok,Lee Yoojin,Yhim Ho-Young,Yang Deok-Hwan,Byun Ja Min,Kang Hye Jin,Kim Hyo Jung,Shin Ho-Jin,Yoo Kwai Han,Suh Cheolwon

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03803-x.pdf

Reference20 articles.

1. Sabattini E, Bacci F, Sagramoso C, Pileri SA (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102:83–87

2. Miller TP, Dahlberg S, Cassady JR et al.1998 Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. 339: 21-26.

3. Herrmann A, Hoster E, Zwingers T et al (2009) Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol 27:511–518

4. Gill BS, Vargo JA, Pai SS et al (2015) Management trends and outcomes for stage I to II mantle cell lymphoma using the National Cancer Data Base: ascertaining the ideal treatment paradigm. Int J Radiat Oncol Biol Phys 93:668–676

5. Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3068

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in hematopoietic stem cell transplantation in Taiwan;Tzu Chi Medical Journal;2024-03-26

2. Stem cell transplant for mantle cell lymphoma in Taiwan;Scientific Reports;2022-04-05

3. Progress in molecular feature of smoldering mantle cell lymphoma;Experimental Hematology & Oncology;2021-07-13

4. Is Limited-Stage Mantle Cell Lymphoma Curable and How Is It Best Managed?;Hematology/Oncology Clinics of North America;2020-10

5. Early-stage mantle cell lymphoma—a rare entity with special characteristics and needs for treatment;Annals of Hematology;2020-09-10